Primary cilia regulate mTORC1 activity and cell size through Lkb1

Nature Cell Biology

Volumn 12, Issue 11, 2010, Pages 1115-1122

  Boehlke, Christopher ^a   Kotsis, Fruzsina ^a   Patel, Vishal ^b   Braeg, Simone ^a   Voelker, Henriette ^a   Bredt, Saskia ^a   Beyer, Theresa ^a   Janusch, Heike ^a   Hamann, Christoph ^a   Gödel, Markus ^a   Müller, Klaus ^a   Herbst, Martin ^a   Hornung, Miriam ^a   Doerken, Mara ^a   Köttgen, Michael ^a   Nitschke, Roland ^c   Igarashi, Peter ^b   Walz, Gerd ^a   Kuehn, E Wolfgang ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; PROTEIN KINASE LKB1; PROTEIN MTORC1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL SIZE; CILIATED EPITHELIUM; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; IN VITRO STUDY; MICTURITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CELL LINE; CELL SIZE; CILIA; DOGS; KINESIN; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA; MUS MUSCULUS;

EID: 78149259013     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb2117     Document Type: Article

References (44)

1. Wullschleger, S., Loewith, R. & Hall, M. N. TOR signaling in growth and metabolism. Cell 124, 471-484 (2006).
2. Laplante, M. & Sabatini, D. M. mTOR signaling at a glance. J. Cell Sci. 122, 3589-3594 (2009).
3. Polak, P. & Hall, M. N. mTOR and the control of whole body metabolism. Curr. Opin. Cell Biol. 21, 209-218 (2009).
4. Ma, X. M. & Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307-318 (2009).
5. Tao, Y., Kim, J., Schrier, R. W. & Edelstein, C. L. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J. Am. Soc. Nephrol. 16, 46-51 (2005).
6. Wahl, P. R. et al. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol. Dial. Transplant 21, 598-604 (2006).
7. Shillingford, J. M. et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl Acad. Sci. USA 103, 5466-5471 (2006).
8. Fliegauf, M., Benzing, T. & Omran, H. When cilia go bad: cilia defects and ciliopathies. Nat. Rev. Mol. Cell Biol. 8, 880-893 (2007).
9. Jansen, M., Ten Klooster, J. P., Offerhaus, G. J. & Clevers, H. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism. Physiol. Rev. 89, 777-798 (2009).
10. Pedersen, L. B. & Rosenbaum, J. L. Intraflagellar transport (IFT) role in ciliary assembly, resorption and signalling. Curr. Top. Dev. Biol. 85, 23-61 (2008).
11. Berbari, N. F., O'Connor, A. K., Haycraft, C. J. & Yoder, B. K. The primary cilium as a complex signaling center. Curr. Biol. 19, R526-535 (2009).
12. Praetorius, H. A. & Spring, K. R. Bending the MDCK cell primary cilium increases intracellular calcium. J. Membr. Biol. 184, 71-79 (2001).
13. Corbit, K. C. et al. Vertebrate Smoothened functions at the primary cilium. Nature 437, 1018-1021 (2005).
14. Haycraft, C. J. et al. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet. 1, e53 (2005).
15. Corbit, K. C. et al. Kif3a constrains β-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms. Nat. Cell Biol. 10, 70-76 (2008).
16. Torres, V. E. & Harris, P. C. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 76, 149-168 (2009).
17. Nauli, S. M. et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33, 129-137 (2003).
18. Serra, A. L. et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 820-829 (2010).
19. Walz, G. et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 830-840 (2010).
20. Distefano, G. et al. Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1. Mol. Cell Biol. 29, 2359-2371 (2009).
21. Grantham, J. J., Geiser, J. L. & Evan, A. P. Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int. 31, 1145-1152 (1987).
22. Patel, V. et al. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum. Mol. Genet. 17, 1578-1590 (2008).
23. Kotsis, F. et al. Ciliary calcium signaling is modulated by kidney injury molecule-1 (Kim1). Pflugers Arch. 453, 819-829 (2007).
24. Kotsis, F., Nitschke, R., Doerken, M., Walz, G. & Kuehn, E. W. Flow modulates centriole movements in tubular epithelial cells. Pflugers Arch. 456, 1025-1035 (2008).
25. Nishimura, T. et al. Role of the PAR-3-KIF3 complex in the establishment of neuronal polarity. Nat. Cell Biol. 6, 328-334 (2004).
26. Pazour, G. J. et al. Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene Tg737, are required for assembly of cilia and flagella. J. Cell Biol. 151, 709-718 (2000).
27. Murcia, N. S. et al. The oak ridge polycystic kidney (orpk) disease gene is required for left-right axis determination. Development 127, 2347-2355 (2000).
28. Chiang, G. G. & Abraham, R. T. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser 2448 is mediated by p70S6 kinase. J. Biol. Chem. 280, 25485-25490 (2005).
29. Kim, D. H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (2002).
30. Polak, P. et al. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab. 8, 399-410 (2008).
31. Yan, L. et al. Hyperactivation of mammalian target of rapamycin (mTOR) signaling by a gain-of-function mutant of the Rheb GTPase. J. Biol. Chem. 281, 19793-19797 (2006).
32. Kottgen, M. et al. TRPP2 and TRPV4 form a polymodal sensory channel complex. J. Cell Biol. 182, 437-447 (2008).
33. Alessi, D. R., Sakamoto, K. & Bayascas, J. R. LKB1-dependent signaling pathways. Annu. Rev. Biochem. 75, 137-163 (2006).
34. Granot, Z. et al. LKB1 regulates pancreatic β cell size, polarity and function. Cell Metab. 10, 296-308 (2009).
35. Sebbagh, M., Santoni, M. J., Hall, B., Borg, J. P. & Schwartz, M. A. Regulation of LKB1/STRAD localization and function by E-cadherin. Curr. Biol. 19, 37-42 (2009).
36. Xie, Z. et al. Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis. Mol. Cell Biol. 29, 3582-3596 (2009).
37. Mammoto, T. & Ingber, D. E. Mechanical control of tissue and organ development. Development 137, 1407-1420 (2010).
38. i response of principal and intercalated cells in cortical collecting duct. Am. J. Physiol. Renal Physiol. 285, F998-F1012 (2003).
39. Maekawa, F. et al. Localization of glucokinase-like immunoreactivity in the rat lower brain stem: for possible location of brain glucose-sensing mechanisms. Endocrinology 141, 375-384 (2000).
40. Zhang, Q., Davenport, J. R., Croyle, M. J., Haycraft, C. J. & Yoder, B. K. Disruption of IFT results in both exocrine and endocrine abnormalities in the pancreas of Tg737 (orpk) mutant mice. Lab. Invest. 85, 45-64 (2005).
41. Wiznerowicz, M. & Trono, D. Conditional suppression of cellular genes: lentivirus vectormediated drug-inducible RNA interference. J. Virol. 77, 8957-8961 (2003).
42. Rekas, A., Alattia, J. R., Nagai, T., Miyawaki, A. & Ikura, M. Crystal structure of venus, a yellow fluorescent protein with improved maturation and reduced environmental sensitivity. J. Biol. Chem. 277, 50573-50578 (2002).
43. Hara, K. et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189 (2002).
44. Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J. & Cantley, L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 10, 151-162 (2002).